Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
View Full LandscapeTarget Indication
Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
Clinical Trial
NCT01668784Last updated: 3/7/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.